Controlling hyperglycemia as an adjunct to cancer therapy

Integrative Cancer Therapies

Volumn 4, Issue 1, 2005, Pages 25-31

  Krone, Cheryl A ^a   Ely, John T A ^b  

^a Applied Research Institute   (New Zealand)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Ascorbic acid; Cancer; Glycohemoglobin; Hyperglycemia; Physical activity

Indexed keywords

ASCORBIC ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ANTIOXIDANT ACTIVITY; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CARBOHYDRATE INTAKE; CELLULAR IMMUNITY; DIET; GLUCOSE BLOOD LEVEL; HEXOSE MONOPHOSPHATE SHUNT; HUMAN; HYPERGLYCEMIA; IMMUNOCOMPETENT CELL; LIFESTYLE; LYMPHOCYTE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REMISSION; REVIEW; SUGAR INTAKE; VITAMIN SUPPLEMENTATION;

ANTINEOPLASTIC AGENTS; DIET; EXERCISE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; IMMUNITY, CELLULAR; LIFE STYLE; NEOPLASMS; PROGNOSIS; SURVIVAL;

EID: 13844273241     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534735404274167     Document Type: Review

References (69)

1. Freund E. Zur diagnose des carcinoms. Wien Med Bl. 1885;8:268.
2. Glicksman AS, Myers WPL, Rawson RW. Diabetes mellitus and carbohydrate metabolism in patients with cancer. Med Clin North Am. 1956;40:887-900.
3. Cheraskin E, Ringedorf WM, Hutchins K, Setyaamadja ATSH, Wideman GL. Carbohydrate metabolism and cervical (uterine) carcinoma. Am J Obst Gyn. 1967;97:817-820.
4. Carter AC, Lefkon BW, Farlin M, Feldman EB. Metabolic parameters in women with metastatic breast cancer. J Clin Endocrinol Metab. 1975;40:260-264.
5. Rofe AM, Bourgeois CS, Coyle P, Taylor A, Abdi EA. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res. 1994;14:647-650.
6. Saruc M, Pour PM. Diabetes and its relationship to pancreatic carcinoma. Pancreas. 2003;26:381-387.
7. Fields M. Nutritional factors adversely influencing the glucose/insulin system. J Am Coll Nurt. 1998;17:317-321.
8. Carroll KK. Dietary factors in hormone-dependent cancers. Curr Concepts Nutr. 1977;6:25-40.
9. Hems G. The contributions of diet and childbearing to breast cancer rates. Br J Cancer. 1978;37:974-982.
10. Tannenbaum A. The initiation and growth of tumors. Am J Cancer. 1940;38:335-350.
11. Visscher MB, Ball ZB, Barnes RH, Sivertsen I. The influence of calorie restriction upon the incidence of spontaneous mammary carcinoma in mice. Surgery. 1942;11:48-55.
12. White DB, White J, Mider GB, Kelly MG, Heston WE. Effect of caloric restriction on mammary tumor formation in strain C3H mice and on the response of strain DBA to painting with methylcholanthrene. J Nat Cancer Inst. 1944;5;43-48.
13. Hochman G. Prevention of cancer: restriction of nutritional energy intake (joules). Comp Biochem Physiol. 1988;91A:209-220.
14. Kritchevsky D. Diet in heart disease and cancer. Adv Exp Med Biol. 1995;369:201-241.
15. Zhu Z, Haegele A, Thompson H. Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis. 1997;18:1007-1012.
16. Koroljow S. Insulin coma therapy. Psychiatr Q. 1962;36:261-270.
17. Marks PA, Bishop JS. Glucose metabolism in subjects with neoplastic disease response to insulin and glucose tolerance followup studies. Proc Am Assoc Cancer Res. 1957;2:228-229.
18. Cheraskin E, Ringedorf WM, Hutchins K, Setyaamadja ATSH, Wideman GL. Effect of diet upon radiation response in cervical carcinoma of the uterus. Acta Cytologica, 1968;12:433-438.
19. Santisteban GA, Ely JTA, Hamel EE, Read DH, Kozawa SM. Glycemic modulation of tumor tolerance in a mouse model of breast cancer. Biochem Biophys Res Commun. 1985;132:1174-1179.
20. Krone CA, Ely JTA. Vitamin C and glycohemoglobin revisited. Clin Chem. 2001;47:148.
21. Krone CA, Ely JTA. Ascorbic acid, glycation, glycohemoglobin and aging. Med Hypotheses. 2004;62:275-279.
22. Yetgin S, Yalcin SS, Ozbek N. Clinical value of glycated hemoglobin and fructosamine in the long-term glycemic control of children with acute lymphoblastic leukemia. Acta Paediatr Jpn. 1998;40:52-56.
23. Willey DG, Rosenthal MA, Caldwell S. Glycosylated hemoglobin and plasma glycoprotein assays by affinity chromatography. Diabetologia. 1984;27:56-58.
24. Pawlak DB, Kushner JA, Ludwig DS. Effects of dietary glycaemic index on adiposity, glucose homeostasis, and plasma lipids in animals. Lancet 2004;364:778-785.
25. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beve rages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537-543.
26. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or obsereed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990;8:1327-1334.
27. Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IE, Asp N-GL, Vessby BOH. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care. 1999;22:10-18.
28. Walford RL, Mock D, Verdery R, MacCallum T. Calorie restriction in Biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Genmtol A Biol Sci Med Sci. 2002;57:B211-B224.
29. Roth GS, Mattison JA, Ottinger MA, Chachicli ME, Lane MA, Ingram DK. Aging in Rhesus monkeys: relevance to human health interventions. Science 2004;305:1423-1426.
30. Goodwill PJ, Ennis M, Pritchard KI, Koo J, Trudeau ME, Hood N. Diet and breast cancer: evidence that extremes in diet are associated with poor survival. J Clin Oncol. 2003;21:2500-2507.
31. Schneider CM, Dennehy CA, Roozeboom M, Carter SD. A model program: exercise intervention for cancer rehabilitation. Integr Cancer Ther. 2002;1:76-82.
32. Rohan TE, Fu W, Hiller JE. Physical activity and survival from breast cancer. Eur J Cancer Prev. 1995;4:419-424.
33. Holmes MD, Chen WY, Feskanich D, Colditz GA. Physical activity and survival after breast cancer diagnosis [abstract]. Proc Am Assoc Cancer Res. 2004;45. Abstract 1462. Available at: http://aacr04.agora.com/planner/ displayabstract.asp?presentationid=640. Accessed December 14, 2004.
34. Holmes MD, Kroenke CH. Beyond treatment: lifestyle choices after breast cancer to enhance quality of life and survival. Womens Health Issues. 2004;14:11-13.
35. Raz I, Hauser E, Bursztyn M. Moderate exercise improves glucose metabolism in uncontrolled elderly patients with non-insulin-dependent diabetes mellitus. Isr J Med Sci. 1994;30:766-770.
36. Gutin B, Cucuzzo N, Islam S, Smith C, Stachura ME. Physical training, lifestyle education, and coronary risk factors in obese girls. Med Sci Sports Exerc. 1996;28:19-23.
37. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69:1086-1107.
38. Fletcher AE, Breeze E, Shetty PS. Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council trial of assessment and management, of older people in the community. Am J Clin Nutr. 2003;78:999-1010.
39. Lesperance ML, Olivotto IA, Norde N, et al. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat. 2002;76:137-143.
40. Hoffer A. Comments on "Mega-dose vitamins and minerals in the treatment of nonmetasialic breast cancer: an historical cohort study." Integr Cancer Ther. 2003;2:155-157.
41. Block KI, Mead MN. Vitamin C in alternative cancer treatment: historical background. Integr Cancer Ther. 2003;2:147-154.
42. Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004;140:533-537.
43. Polidori MC, Mecocci P, Levine M, Frei B. Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasm a to ex vivo lipid peroxidation. Arch Biochem Biophys. 2004;423:109-115.
44. Kelly DS, Bencich A. Essential nutrients and immunologic functions. Am J Clin Nutr. 1996;63:994S-996S.
45. Marcus SL, Dutcher JP, Paietta E, et al. Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells. Cancer Res. 1987;47:4208-4212.
46. Ely JTA. Hyperglycemia and major congenital anomalies. N Engl J Med. 1981;305:833.
47. Ely JTA. Acute cellular anergy of hyperglycemia [abstract], Bull Am Phys Soc. 1983;28:54.
48. Ely JTA, Spackman DH. Hexose monophosphate shunt suppression in leukocytes and tumor-cells [abstract]. Proc Am Assoc Cancer Res. 1983;24:814.
49. Ely JTA. Glycemic modulation of tumor tolerance. J Orthomolecular Med. 1996;11:23-34.
50. Roitt I. Essential Immunology. 7th ed. Oxford, UK: Blackwell; 1991.
51. Puskas F, Gergely P Jr, Banki K, Perl A. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB J. 2000;14:1352-1361.
52. Cooper MR, McCall CE, DeChatelet LR. Stimulation of leukocyte hexose monophosphate shunt activity by ascorbic acid. Infect Immun. 1971;3:851-853.
53. Rumsey SC, Kwon O, Xu GW, Burant CF, Simpson I, Levine M. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem. 1997;272:18982-18989.
54. Lenton KJ, Sane AT, Therriault H, Gantin AM, Payette H, Wagner JR. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am J Clin Nutr. 2003;77:189-195.
55. Jacob RA, Pianalto FS, Agee RE. Cellular ascorbate depletion in healthy men. J Nutr. 1992;122:1111-1118.
56. Bergsten P, Amitai G, Kehrl J, Dhariwal KR, Klein HG, Levine M. Millimolar concentrations of ascorbic acid in purified human mononuclcar leukocytes: depletion and reaccumulation. J Biol Chem. 1990;265:2584-2587.
57. Lemon KJ, Therriault H, Cantin AM, Fulop T, Payette H, Wagner JR. Direct correlation of glutathione and ascorbate and their dependence on age and season in human lymphocytes. Am J Clin Nutr. 2000;71:1194-1200.
58. Washko PW, Wang Y, Levine M. Ascorbic acid recycling in human neutrophils. J Biol Chem. 1993;268:15531-15535.
59. Chen MS, Hutchinson ML, Pecoraro RE, Lee WYL, Labbe RF. Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes. 1983; 32:1078-1081.
60. Davis KA, Lee WYL, Labbe RF. Energy dependent transport of ascorbic acid into lymphocytes. Fed Proc. 1983;42:2011.
61. Sanchez A, Reeser JL, Lau HS, et al. Role of sugars in human neutrophilic phagocytosis. Am J Clin Nutr. 1973;26:1180-1184.
62. Boldizsar F, Berki T, Miseta A, Nemeth P. Effect of hyperglycemia on the basal cytosolic free calcium level, calcium signal and tyrosine-phosphorylation in human T-cells. Immunol Lett. 2002;82:159-164.
63. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-265.
64. Matsuda M, Petersson M, Lenkei R, et al. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal, and peripheral lymphocytes: correlation with the stage of the disease. Int J Cancer. 1995;61:765-772.
65. Gerstein HC. Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor. Ann Intern Med. 2004;141:475-476.
66. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413-420.
67. Khaxv KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women-a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004;13:915-919.
68. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992-1000.
69. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236:814-822.